← Browse by Condition
Medical Condition
locally advanced breast cancer
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1, Phase 2, Phase 3
NCT06064812 Phase 1, Phase 2
Recruiting
A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.
Enrollment
99 pts
Location
China
Sponsor
Forward Pharmaceuticals Co., L...
NCT07024173 Phase 3
Recruiting
A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer
Enrollment
240 pts
Location
China
Sponsor
Shandong Suncadia Medicine Co....
NCT07347600
Recruiting
A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
Enrollment
500 pts
Location
China
Sponsor
Hoffmann-La Roche
NCT06827236 Phase 1, Phase 2
Recruiting
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Enrollment
380 pts
Location
United States, Canad...
Sponsor
BioNTech SE
NCT06605521
Recruiting
To Evaluate the Efficacy and Safety of Ipsilateral Supraclavicular Lymph Node Dissection for Breast Cancer Patients
Enrollment
300 pts
Location
China
Sponsor
Henan Cancer Hospital